Buscar resultados de ensayos clínicos
Familial Hypophosphatemic Rickets - 21 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Calcimimetics in Hypophosphatemic Rickets Condición: Familial Hypophosphatemic Rickets Fecha: 2009-02-12 Intervenciones: Drug: Cinacalcet Stable patients with XLH already treated with Phosphate and calcitriol will add Cinacal |
Completed |
Nombre del estudio: A Study of KRN23 in X-linked Hypophosphatemia Condición: X-linked Hypophosphatemia Fecha: 2009-01-27 Intervenciones:
|
Completed |
Nombre del estudio: A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia Condición: X-linked Hypophosphatemia Fecha: 2011-04-15 Intervenciones: Drug: KRN23 Subjects will receive escalating doses of KRN23 administered by SC injections every 28-days |
Completed |
Nombre del estudio: An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia Condición: X-linked Hypophosphatemia Fecha: 2012-02-23 Intervenciones: Drug: KRN23 Subjects will receive escalating doses of KRN23 administered by SC injection every 28-days ( |
Enrolling by invitation |
Nombre del estudio: Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH) Condición: X-Linked Hypophosphatemia Fecha: 2014-12-03 Intervenciones: Drug: KRN23 KRN23 is a recombinant fully human immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that b |
Active, not recruiting |
Nombre del estudio: Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH) Condición: X-linked Hypophosphatemia Fecha: 2015-07-17 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Study of KRN23, a Recombinant Fully Human Monoclonal Antibody Against FGF23, in Pediatric Subjects With X-linked Hypophosphatemia (XLH) Condición: X-linked Hypophosphatemia Fecha: 2014-06-09 Intervenciones: Drug: KRN23 |
Active, not recruiting |
Nombre del estudio: Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH) Condición: X-linked Hypophosphatemia Fecha: 2015-08-25 Intervenciones: Biological: KRN23 KRN23 is a recombinant human immunoglobulin G isotype 1 (IgG1) monoclonal antibody (mA |
Active, not recruiting |
Nombre del estudio: Study of the Safety, Pharmacodynamics and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH) Condición: X-Linked Hypophosphatemia Fecha: 2015-12-06 Intervenciones: Drug: KRN23 |
Recruiting |
Nombre del estudio: Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH) Condición: X-Linked Hypophosphatemia Fecha: 2016-05-23 Intervenciones:
|